Corrigendum: Incidence and management of diarrhea in patients with HER2-positive breast cancer treated with pertuzumab (Annals of Oncology (2017) 28 (761-768) DOI: 10.1093/annonc/mdw695)

  1. Swain, S.M.
  2. Schneeweiss, A.
  3. Gianni, L.
  4. Gao, J.J.
  5. Stein, A.
  6. Waldron-Lynch, M.
  7. Heeson, S.
  8. Beattie, M.S.
  9. Yoo, B.
  10. Cortes, J.
  11. Baselga, J.
Journal:
Annals of Oncology

ISSN: 1569-8041 0923-7534

Year of publication: 2019

Volume: 30

Issue: 8

Pages: 1404

Type: Erratum

DOI: 10.1093/ANNONC/MDY538 GOOGLE SCHOLAR lock_openOpen access editor

Sustainable development goals